fbpx

Equity Research of
Nordic Growth Companies

QLUCORE: Structural growth story on track with a slight expansion of long-term scope

Analys, Research

After the strong growth in Q1’22/23, sales bounced back in Q2’22/23, right in line with our forecast. With the process to CE marking of...

Read More

MOTION DISPLAY: Bright spots shining through persistent headwind

Analys, Research

The hangover from the pandemic continues to linger for Motion Display. But there are bright spots. With a well-documented effect on sales,...

Read More

KEBNI: New targets reflect high conviction in strong growth across the board in 2023-2027

Analys, Research

The announcement of KebNi’s revised strategy and financial targets for 2023-2027 reflect a firm conviction in steady long term growth...

Read More

MELTRON: Focus set on positive cash flow

Analys, Research

After a cash injection of SEK 11.3m from the completed rights issue, Meltron now has its sights set on positive cash flow through sales...

Read More

TALLINK: Ingen oro inför lågsäsongen

Okategoriserade

ANALYSSAMARBETE MED ENLIGHT RESEARCH  Både omsättning och vinst var över våra estimat i Q3. Rekordhöga uthyrningsintäkter kan...

Read More

SIMRIS ALG: Ready to execute on a three-pronged roadmap to capture the most high-value opportunities

Analys, Research

Following the successful acquisition of Cyano Biotech GmbH in Q3, Simris is now moving forward with a three-pronged approach to value...

Read More

DLABORATORY: Strong growth and positive EBITDA a welcome shift in pace

Analys, Research

With a steep increase in revenue, 35% recurring revenue growth, turn to positive EBITDA of SEK 2.2m and a forward-leaning statement from...

Read More

TRADING IDEA – Short DAX – Stage set for a pullback   

TRADING IDEA

Image credit: TradingView Trading idea – Short DAX – Stage set for a pullback    After the strength seen across the...

Read More

NANEXA: Charging to enter triple clinical trials in the coming year

Analys, Research

Besides starting its third proprietary development project in Q2 (NEX-22, a long-acting formulation of liraglutide for treatment of type 2...

Read More

KEBNI: Saab order the portal to next level for KebNi

Analys, Research

With the SEK 76m volume order for IMUs from Saab, KebNi now enters the next level of monetising its IMU technology. The order however only...

Read More

Be first to read new research on growth stocks